Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Nuclear factor erythroid 2-related factor 2 (Nrf2) is a master regulator of cellular antioxidant and detoxification responses.
• Nrf2 plays a critical role in combating oxidative and electrophilic stress, maintaining cellular redox homeostasis.
• Pulmonary hypertension (PH) is a complex disease associated with increased oxidative stress and impaired antioxidant capacity.

Purpose of the Study:

• To review the multifaceted role of Nrf2 in the pathophysiology of pulmonary hypertension.
• To explore the therapeutic potential of Nrf2 activators, particularly natural phytochemicals, in PH treatment.
• To summarize current research on Nrf2 agonists in experimental and clinical studies of PH.

Main Methods:

• Literature review of studies investigating Nrf2 in pulmonary hypertension models.
• Analysis of research on natural phytochemicals as Nrf2 activators.
• Examination of experimental and clinical trial data on Nrf2 agonists for PH.

Main Results:

• Nrf2 activation demonstrates significant protective effects in various experimental models of pulmonary hypertension.
• Natural phytochemicals acting as Nrf2 agonists have shown efficacy in preventing PH development.
• Evidence suggests Nrf2 plays a crucial role in mitigating PH progression and severity.

Conclusions:

• Nrf2 is a key molecular target for the treatment of pulmonary hypertension.
• Nrf2 activators, especially those derived from natural sources, represent a promising therapeutic strategy for PH.
• Further research and clinical trials are warranted to fully elucidate the therapeutic benefits of Nrf2 modulation in PH.